In a competitive market, with both start-ups and established companies constantly working on the development of new drugs and clinical trials, it is easy to forget the amount of investment that goes in to each company. Despite the considerable amount of companies that 'blow up' there are only a special few that actually make it HUGE and the rest are often forgotten.
The cost, the risk, the patients that take place in the trials, again, all are often overlooked. I truly believe that one of the most important decisions that these companies make, with all of this in mind, is the people that they hire and employ. With the right drug or technology combined with the right people, these start-ups and even the 'Big Pharma' companies can really become something special (or even more special than they already are). At SciPro we really enjoy growing with a client. Helping them to write their story and ensuring we find the talent that they need to make their team the best out there.
The nature of our industry means people do move companies and its crucial that each client have partners that can help support their growth.
If you would like to learn more about the clients we currently work with, or indeed if you would like to discuss how we can help grow your team please don't hesitate to reach out. In the meantime see below a great article that highlights some key insights to the Biotech world...
Clinical trials fail all the time for big pharma and small biotechs alike, and investors are aware of that. But a certain subset of biotechs -- those working on newer or riskier methods of attacking a disease, such as RNAi, cell therapy, or gene therapy -- have substantially more risk